Skip to main content
. 2021 May 22;13(6):778. doi: 10.3390/pharmaceutics13060778

Figure 2.

Figure 2

Simulation of the absorbed CAB fractions in different intestine sections after administration of a CAB 140 mg solution (A), tablet (B) and capsule formulation (C).